Is het China Resources Medical Holdings Company dividend veilig?
China Resources Medical Holdings Company verhoogt het dividend al 2 jaar.
Binnen de laatste 10 jaar heeft China Resources Medical Holdings Company deze met jaarlijks 0 % verlaagd verhoogd.
Op 5-jaarsbasis is de uitkering met daalde toegenomen met 0 %.
De analisten verwachten voor het lopende boekjaar een Dividendverlaging van 0%.
China Resources Medical Holdings Company Aktienanalyse
Wat doet China Resources Medical Holdings Company?
China Resources Medical Holdings Company Limited (CR Medical) is a leading healthcare service provider in China. It was established in 2001 and is headquartered in Hong Kong. The company belongs to China Resources Group, one of the largest companies in China.
History:
CR Medical has a long history and experience in the healthcare sector. It was founded in Hong Kong in 2001 and in the same year, it also acquired Chengdu Xinhua Hospital, one of the largest hospitals in China.
In 2015, the company opened its first medical center in Hong Kong. In 2016, it opened the first China Wellness Center (CWC) in Beijing and the first medical center in Shanghai to promote the growth of its healthcare services in China.
In 2018, the company expanded its healthcare services through the acquisition of Bayley & Jackson Medical Centre, a renowned private hospital in Hong Kong.
Business model:
CR Medical is an integrated healthcare company. It offers a wide range of services, including hospitals, medical centers, pharmacies, healthcare products, and diagnostic and pathology services.
The company consists of three main divisions: China Resources Peking Hospital, China Resources Xian Military Hospital, and China Resources Bayley & Jackson Medical Centre. Each of these divisions offers a wide range of healthcare services.
Products and services:
CR Medical provides a wide range of healthcare services, including hospitals, medical centers, pharmacies, healthcare products, and diagnostic and pathology services.
Hospitals: CR Medical operates several hospitals in China, including China Resources Peking Hospital, China Resources Xian Military Hospital, and Bayley & Jackson Medical Centre in Hong Kong.
Medical centers: The company also operates multiple medical centers in China and Hong Kong, including China Wellness Center and CR Xian Hanguang Health Management Center.
Pharmacies: CR Medical is also a leading provider of pharmacies in China. It operates over 370 pharmacies in China under the name Mims.
Healthcare products: CR Medical also produces its own healthcare products, including traditional Chinese medicine, dietary supplements, and cosmetics.
Diagnostic and pathology services: CR Medical also offers diagnostic and pathology services to monitor and improve customers' health.
Conclusion:
CR Medical is a leading healthcare service provider in China. The company operates hospitals, medical centers, pharmacies, and produces healthcare products. CR Medical is an integrated healthcare company providing a wide range of services to improve the health of its customers. China Resources Medical Holdings Company is een van de populairste bedrijven op Eulerpool.com.Aandelen spaarplannen bieden een aantrekkelijke mogelijkheid voor beleggers om op de lange termijn vermogen op te bouwen. Een van de belangrijkste voordelen is het zogenaamde cost-average-effect: door regelmatig een vast bedrag in aandelen of aandelenfondsen te investeren, koopt men automatisch meer aandelen wanneer de prijzen laag zijn, en minder wanneer ze hoog zijn. Dit kan leiden tot een voordeligere gemiddelde prijs per aandeel over de tijd. Bovendien maken aandelen spaarplannen het ook voor kleine beleggers mogelijk om toegang te krijgen tot dure aandelen, aangezien ze al met kleine bedragen kunnen deelnemen. De regelmatige investering bevordert ook een gedisciplineerde beleggingsstrategie en helpt emotionele beslissingen, zoals impulsief kopen of verkopen, te voorkomen. Daarnaast profiteren beleggers van de potentiële waardestijging van de aandelen en van dividenduitkeringen die herinvesteerd kunnen worden, wat het effect van samengestelde interest versterkt en daarmee de groei van het geïnvesteerde kapitaal.